by Vincent Van der Wel | Apr 21, 2026 | Blog
Original post: 11 Aug 2025 | Updated: 21 Apr 2026 Developing a medicine that is accessible for patients remains a big challenge, especially in areas like rare diseases or drug repurposing. Researchers publish new papers with potential treatments every day, but the...
by Vincent Van der Wel | Apr 12, 2026 | Webinar
Webinar: how do you generate impact through a spin-off? 18 June 2026, 16:00 CEST Register here Learn how to build a venture to turn science into reality. Socially, Responsible. After this session you will: Know which impact routes are available for promising...
by Vincent Van der Wel | Feb 11, 2025 | Blog
Over the past decades its popularity has increased, especially amongst academics. In 2010, there were only 57 publications on drug repurposing. By 2024, this number has increased to over 2300 publications, reflecting the increased interest and activity in the field of...
by Vincent Van der Wel | Jul 25, 2024 | Blog
It is no secret that much money is involved in the pharmaceutical industry. Many types of medicine are expensive to develop and manufacture. The financing of healthcare is very complex. The pharmaceutical industry is exciting, but sometimes rightly, sometimes wrongly,...
by Vincent Van der Wel | Jul 19, 2024 | Blog
Orfenix focuses on making innovative Life Sciences and Health solutions accessible and affordable. For example, they run projects to make specific medications available to patients affordably. They achieve this by developing strong business cases prioritizing a fair...
